标题
Expanding access to CAR T cell therapies through local manufacturing
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-27
DOI
10.1038/s41587-023-01981-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
- (2023) Sham Mailankody et al. NATURE MEDICINE
- Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
- (2023) Robert Chiesa et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy
- (2023) Nausheen Ahmed et al. Frontiers in Oncology
- The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001
- (2022) Esteve Trias et al. BONE MARROW TRANSPLANTATION
- Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products
- (2022) Natividad Cuende et al. CYTOTHERAPY
- Engineered cellular immunotherapies in cancer and beyond
- (2022) Amanda V. Finck et al. NATURE MEDICINE
- Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers
- (2022) Frank J. Lowery et al. SCIENCE
- GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18
- (2022) Wolfgang Glienke et al. Frontiers in Immunology
- Ethical challenges with CAR T slot allocation with idecabtagene vicleucel manufacturing access.
- (2022) Taxiarchis Kourelis et al. JOURNAL OF CLINICAL ONCOLOGY
- Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital
- (2022) Simon Hort et al. Frontiers in Medicine
- Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia
- (2022) Giorgio Ottaviano et al. Science Translational Medicine
- Potential solutions for manufacture of CAR T cells in cancer immunotherapy
- (2022) Ulrich Blache et al. Nature Communications
- UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
- (2022) Reuben Benjamin et al. Lancet Haematology
- Automated, scaled, transposon-based production of CAR T cells
- (2022) Dominik Lock et al. Journal for ImmunoTherapy of Cancer
- Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma
- (2022) Raghad Alqazaqi et al. JAMA Network Open
- Real-World Impact of Time from Leukapheresis to Infusion (Vein-to-Vein Time) in Patients with Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel
- (2022) Frederick L. Locke et al. BLOOD
- Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India
- (2022) Hamenth Kumar Palani et al. BONE MARROW TRANSPLANTATION
- Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
- (2022) Samer Al Hadidi et al. BONE MARROW TRANSPLANTATION
- Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
- (2022) Maartje W. Rohaan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation
- (2021) Ching Lam et al. CYTOTHERAPY
- A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells
- (2021) Matthias Bozza et al. Science Advances
- Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia
- (2021) Jenna Rossoff et al. BLOOD
- Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
- (2021) Katie Palen et al. CYTOTHERAPY
- Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
- (2021) Michael Maschan et al. Nature Communications
- Regulatory hurdles for CAR T-cell therapy in Japan
- (2021) Sumimasa Nagai Lancet Haematology
- An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies
- (2021) Lequina Myles et al. CYTOTHERAPY
- Accelerating clinical-scale production of BCMA CAR T cells with defined maturation stages
- (2021) Jara J. Joedicke et al. Molecular Therapy-Methods & Clinical Development
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-human data of ALLO-501 and ALLO-647 in relapsed/refractory large B-cell or follicular lymphoma (R/R LBCL/FL): ALPHA study.
- (2020) Sattva Swarup Neelapu et al. JOURNAL OF CLINICAL ONCOLOGY
- Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
- (2020) Maria Castella et al. Frontiers in Immunology
- Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries
- (2020) Delphi G.M. Coppens et al. CYTOTHERAPY
- Cost of decentralized CAR T‐cell production in an academic nonprofit setting
- (2020) Tao Ran et al. INTERNATIONAL JOURNAL OF CANCER
- Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
- (2020) Silvia Arcangeli et al. Frontiers in Immunology
- Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
- (2020) Zachary Jackson et al. Frontiers in Immunology
- Classification of T-cell activation via autofluorescence lifetime imaging
- (2020) Alex J. Walsh et al. Nature Biomedical Engineering
- Challenges and advantages of cell therapy manufacturing under Good Manufacturing Practices within the hospital setting
- (2020) Emanuela M Iancu et al. CURRENT OPINION IN BIOTECHNOLOGY
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies
- (2020) Valentín Ortíz-Maldonado et al. MOLECULAR THERAPY
- Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
- (2020) Nirav N. Shah et al. NATURE MEDICINE
- Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
- (2020) Reuben Benjamin et al. LANCET
- Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
- (2019) Yogindra Vedvyas et al. Scientific Reports
- CAR T cell viability release testing and clinical outcomes: is there a lower limit?
- (2019) Elise A. Chong et al. BLOOD
- A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies
- (2019) KAN WANG et al. CYTOTHERAPY
- GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
- (2019) Lucía Fernández et al. Frontiers in Immunology
- Decentralised manufacturing of cell and gene therapy products: Learning from other healthcare sectors
- (2018) Richard P. Harrison et al. BIOTECHNOLOGY ADVANCES
- Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
- (2018) Franziska Blaeschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center
- (2018) Fenlu Zhu et al. CYTOTHERAPY
- Balancing Safety and Innovation for Cell-Based Regenerative Medicine
- (2018) Peter Marks et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Reducing Ex Vivo Culture Improves the Anti-leukemic Activity of Chimeric Antigen Receptor (CAR)-T Cells
- (2018) Saba Ghassemi et al. Cancer Immunology Research
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-Dimensional Label-Free Affinity Analysis of Tumor-Specific CD8 T Cells with a Biomimetic Plasmonic Sensor
- (2018) Maria Soler et al. ACS Sensors
- Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions
- (2018) Maria Castella et al. Molecular Therapy-Methods & Clinical Development
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Label-free optical biosensor for on-line monitoring the integrated response of human B cells upon the engagement of stimulatory and inhibitory immune receptors
- (2017) Istvan Kurucz et al. SENSORS AND ACTUATORS B-CHEMICAL
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- The why, what, and how of the new FACT standards for immune effector cells
- (2017) Marcela V. Maus et al. Journal for ImmunoTherapy of Cancer
- Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy
- (2016) Ulrike Mock et al. CYTOTHERAPY
- Redefining the role of blood establishments as raw material suppliers, manufacturers, and distributors for new cell therapies: the Blood Systems experience
- (2016) Frank Nizzi TRANSFUSION
- Multiplexed Nanoplasmonic Temporal Profiling of T-Cell Response under Immunomodulatory Agent Exposure
- (2016) Bo-Ram Oh et al. ACS Sensors
- Future Supply Chains Enabled by Continuous Processing—Opportunities Challenges May 20–21 2014 Continuous Manufacturing Symposium
- (2015) Jagjit Singh Srai et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns
- (2014) Natividad Cuende et al. CYTOTHERAPY
- Quantitative Imaging of Protein Secretions from Single Cells in Real Time
- (2013) Marc P. Raphael et al. BIOPHYSICAL JOURNAL
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More